Search Results

CSL Behring's mission is to discover, develop, and deliver our innovative therapies that improve the patients' quality of life.

https://www.cslbehring.ca/research-and-development/r-and-d-capabilities

In the event of a positive result, We will enter into collaboration agreements to address implement transactions that are aligned with our business employees must contact CSL Global Trade Compliance partnership aspects, including the respect and protection activity, have clear commercial objectives, and do not rely for further investigation.

https://www.cslbehring.ca/-/media/csl/documents/crbp-languages/csl_crbp2021_english_external.pdf

Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise thereby ensuring our continued growth.

https://www.cslbehring.ca/research-and-development/product-pipeline

Phase III Phase II/III Phase III AAT (CSL964) AAT (CSL964) Clazakizumab (CSL300) treatment study in MODULAATE IMAGINE trial Interleukin 6 Blockade Modifying Antibody- collaboration with BMT prevention study Mediated Graft Injury and Estimated CTN (NHLBI/NCI) Glomerular Filtration Rate (eGFR) Decline 1 2 3

https://www.cslbehring.ca/-/media/shared/documents/7/rd-investor-briefing-2020.pdf

More than 100 years ago, CSL was formed to save lives using the latest technologies. In the century since, CSL Behring has grown into a global biotechnology leader, driven by that same promise to save and improve lives.

https://www.cslbehring.ca/our-company

Innovation is in our DNA and is the core of everything we do at CSL Behring.

https://www.cslbehring.ca/research-and-development

CSL continues to provide medicines to patients around the world.

https://www.cslbehring.ca/news/2020/covid-19-update

CSL / Momenta Collaboration •

https://www.cslbehring.ca/-/media/shared/documents/7/rd-investor-briefing-2017.pdf

CSL Behring and SAB Therapeutics Join Forces to Deliver New Potential COVID-19 Therapeutic

https://www.cslbehring.ca/news/2020/csl-and-sab-therapeutics

Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19

https://www.cslbehring.ca/news/2020/global-plasma-leaders-collaborate